{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:25:24Z","timestamp":1792689924412,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Clarithromycin is a macrolide antibiotic widely used for eradication of\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    infection, and thus resistance to this antibiotic is a major cause of treatment failure. Here, we present the results of a retrospective observational study of clarithromycin resistance (Cla-res) in 4744\n                    <jats:italic>H. pylori<\/jats:italic>\n                    -infected patients from Central Hungary. We use immunohistochemistry and fluorescence in situ hybridization on fixed gastric tissue samples to determine\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection and to infer Cla-res status, respectively. We correlate this information with macrolide dispensing data for the same patients (available through a prescription database) and develop a mathematical model of the population dynamics of Cla-res\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infections. Cla-res is found in 5.5% of macrolide-naive patients (primary Cla-res), with no significant sex difference. The model predicts that this primary Cla-res originates from transmission of resistant bacteria in 98.7% of cases, and derives from spontaneous mutations in the other 1.3%. We find an age-dependent preponderance of female patients among secondary (macrolide-exposed) clarithromycin-resistant infections, predominantly associated with prior use of macrolides for non-eradication purposes. Our results shed light into the sources of primary resistant cases, and indicate that the growth rate of Cla-res prevalence would likely decrease if macrolides were no longer used for purposes other than\n                    <jats:italic>H. pylori<\/jats:italic>\n                    eradication.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-22557-7","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T06:30:49Z","timestamp":1618468249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-1323","authenticated-orcid":false,"given":"\u00c9va","family":"Kocsm\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy Mikl\u00f3s","family":"Buz\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"Szirtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8031-2463","authenticated-orcid":false,"given":"Ildik\u00f3","family":"Kocsm\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Szij\u00e1rt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Fadgyas-Freyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kat\u00f3","family":"Sz\u00e9n\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6515-5482","authenticated-orcid":false,"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9476-3284","authenticated-orcid":false,"given":"Gergely","family":"R\u00f6st","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-8978","authenticated-orcid":false,"given":"G\u00e1bor","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"22557_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi, J. K. Y. et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153, 420\u2013429 (2017).","journal-title":"Gastroenterology"},{"key":"22557_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner, P. et al. Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report. Gut 66, 6\u201330 (2017).","journal-title":"Gut"},{"key":"22557_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00054-05","volume":"19","author":"JG Kusters","year":"2006","unstructured":"Kusters, J. G., van Vliet, A. H. M. & Kuipers, E. J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19, 449\u2013490 (2006).","journal-title":"Clin. Microbiol. Rev."},{"key":"22557_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4291\/wjgp.v2.i3.35","volume":"2","author":"VD Francesco","year":"2011","unstructured":"Francesco, V. D. et al. Mechanisms of Helicobacter pylori antibiotic resistance: an updated appraisal. World J. Gastrointest. Pathophysiol. 2, 35\u201341 (2011).","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"22557_CR5","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1111\/j.1440-1746.2009.06220.x","volume":"25","author":"K Hirata","year":"2010","unstructured":"Hirata, K. et al. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J. Gastroenterol. Hepatol. 25, S75\u2013S79 (2010).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"22557_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1574-6968.2000.tb09117.x","volume":"186","author":"DA Israel","year":"2000","unstructured":"Israel, D. A., Lou, A. S. & Blaser, M. J. Characteristics of Helicobacter pylori natural transformation. FEMS Microbiol. Lett. 186, 275\u2013280 (2000).","journal-title":"FEMS Microbiol. Lett."},{"key":"22557_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fmolb.2014.00019","volume":"1","author":"T Nishizawa","year":"2014","unstructured":"Nishizawa, T. & Suzuki, H. Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing. Front. Mol. Biosci. 1, 19 (2014).","journal-title":"Front. Mol. Biosci"},{"key":"22557_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s00535-014-0938-y","volume":"49","author":"E Fernandez-Gonzalez","year":"2014","unstructured":"Fernandez-Gonzalez, E. & Backert, S. DNA transfer in the gastric pathogen Helicobacter pylori. J. Gastroenterol. 49, 594\u2013604 (2014).","journal-title":"J. Gastroenterol."},{"key":"22557_CR9","first-page":"e02530","volume":"61","author":"D Chen","year":"2017","unstructured":"Chen, D. et al. Phenotypic and molecular antimicrobial susceptibility of Helicobacter pylori. Antimicrob. Agents Chemother. 61, e02530\u201316 (2017).","journal-title":"Agents Chemother"},{"key":"22557_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","volume":"2","author":"Y-T Kuo","year":"2017","unstructured":"Kuo, Y.-T. et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2, 707\u2013715 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"22557_CR11","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.7314\/APJCP.2015.16.18.8281","volume":"16","author":"T Tongtawee","year":"2015","unstructured":"Tongtawee, T. et al. High prevalence of Helicobacter pylori resistance to clarithromycin: a hospital-based cross-sectional study in Nakhon Ratchasima Province, Northeast of Thailand. Asian Pac. J. Cancer Prev. 16, 8281\u20138285 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"22557_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"22557_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey, W. D., Leontiadis, G. I., Howden, C. W. & Moss, S. F. ACG clinical guideline: treatment of Helicobacter pylori Infection. Am. J. Gastroenterol. 112, 212\u2013239 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"22557_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/gut.2003.022111","volume":"53","author":"F M\u00e9graud","year":"2004","unstructured":"M\u00e9graud, F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53, 1374\u20131384 (2004).","journal-title":"Gut"},{"key":"22557_CR15","doi-asserted-by":"publisher","first-page":"e0124199","DOI":"10.1371\/journal.pone.0124199","volume":"10","author":"J-M Liou","year":"2015","unstructured":"Liou, J.-M. et al. The primary resistance of Helicobacter pylori in taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors-a nationwide study. PLoS ONE 10, e0124199 (2015).","journal-title":"PLoS ONE"},{"key":"22557_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1046\/j.1523-5378.2002.00096.x","volume":"7","author":"L Perez Aldana","year":"2002","unstructured":"Perez Aldana, L. et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7, 306\u2013309 (2002).","journal-title":"Helicobacter"},{"key":"22557_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14787210.2018.1511427","volume":"16","author":"DY Graham","year":"2018","unstructured":"Graham, D. Y., Dore, M. P. & Lu, H. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies. Expert Rev. Anti Infect. Ther. 16, 679\u2013687 (2018).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"22557_CR18","first-page":"CD011825","volume":"2019","author":"MP Hansen","year":"2019","unstructured":"Hansen, M. P. et al. Adverse events in people taking macrolide antibiotics versus placebo for any indication. Cochrane Database Syst. Rev. 2019, CD011825 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"22557_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","volume":"62","author":"F Megraud","year":"2013","unstructured":"Megraud, F. et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 62, 34\u201342 (2013).","journal-title":"Gut"},{"key":"22557_CR20","doi-asserted-by":"publisher","first-page":"e12670","DOI":"10.1111\/hel.12670","volume":"25","author":"\u00c9 Kocsm\u00e1r","year":"2020","unstructured":"Kocsm\u00e1r, \u00c9. et al. Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept. Helicobacter 25, e12670 (2020).","journal-title":"Helicobacter"},{"key":"22557_CR21","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41564-019-0565-8","volume":"4","author":"MC Fitzpatrick","year":"2019","unstructured":"Fitzpatrick, M. C., Bauch, C. T., Townsend, J. P. & Galvani, A. P. Modelling microbial infection to address global health challenges. Nat. Microbiol. 4, 1612\u20131619 (2019).","journal-title":"Nat. Microbiol."},{"key":"22557_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1314-9","volume":"17","author":"AM Niewiadomska","year":"2019","unstructured":"Niewiadomska, A. M. et al. Population-level mathematical modeling of antimicrobial resistance: a systematic review. BMC Med. 17, 81 (2019).","journal-title":"BMC Med."},{"key":"22557_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3201\/eid0603.000302","volume":"6","author":"MFT Rupnow","year":"2000","unstructured":"Rupnow, M. F. T., Shachter, R. D., Owens, D. K. & Parsonnet, J. A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. Emerg. Infect. Dis. 6, 228\u2013237 (2000).","journal-title":"Emerg. Infect. Dis."},{"key":"22557_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijid.2019.05.028","volume":"85","author":"C Kenyon","year":"2019","unstructured":"Kenyon, C. Population-level macrolide consumption is associated with clarithromycin resistance in Helicobacter pylori: an ecological analysis. Int. J. Infect. Dis. 85, 67\u201369 (2019).","journal-title":"Int. J. Infect. Dis."},{"key":"22557_CR25","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.cgh.2015.02.005","volume":"13","author":"S Shiota","year":"2015","unstructured":"Shiota, S., Reddy, R., Alsarraj, A., El-Serag, H. B. & Graham, D. Y. Antibiotic resistance of Helicobacter pylori among male United States veterans. Clin. Gastroenterol. Hepatol. 13, 1616\u20131624 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"22557_CR26","doi-asserted-by":"publisher","first-page":"hel.12440","DOI":"10.1111\/hel.12440","volume":"22","author":"F Mac\u00edas-Garc\u00eda","year":"2017","unstructured":"Mac\u00edas-Garc\u00eda, F., Llovo-Taboada, J., D\u00edaz-L\u00f3pez, M., Bast\u00f3n-Rey, I. & Dom\u00ednguez-Mu\u00f1oz, J. E. High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: a prevalence cross-sectional study in Spain. Helicobacter 22, hel.12440 (2017).","journal-title":"Helicobacter"},{"key":"22557_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tics.2011.08.004","volume":"15","author":"DL Schacter","year":"2011","unstructured":"Schacter, D. L., Guerin, S. A. & St Jacques, P. L. Memory distortion: an adaptive perspective. Trends Cogn. Sci. (Regul. Ed.) 15, 467\u2013474 (2011).","journal-title":"Trends Cogn. Sci. (Regul. Ed.)"},{"key":"22557_CR28","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1080\/10408398.2016.1164119","volume":"57","author":"L Tian","year":"2017","unstructured":"Tian, L., Khalil, S. & Bayen, S. Effect of thermal treatments on the degradation of antibiotic residues in food. Crit. Rev. Food Sci. Nutr. 57, 3760\u20133770 (2017).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"22557_CR29","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1128\/JCM.42.8.3901-3903.2004","volume":"42","author":"I Taneike","year":"2004","unstructured":"Taneike, I., Suzuki, K., Nakagawa, S. & Yamamoto, T. Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis. J. Clin. Microbiol. 42, 3901\u20133903 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"22557_CR30","doi-asserted-by":"publisher","first-page":"e1001036","DOI":"10.1371\/journal.pgen.1001036","volume":"6","author":"G Morelli","year":"2010","unstructured":"Morelli, G. et al. Microevolution of Helicobacter pylori during prolonged infection of single hosts and within families. PLoS Genet. 6, e1001036 (2010).","journal-title":"PLoS Genet."},{"key":"22557_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5165","volume":"5","author":"B Linz","year":"2014","unstructured":"Linz, B. et al. A mutation burst during the acute phase of Helicobacter pylori infection in humans and rhesus macaques. Nat. Commun. 5, 4165 (2014).","journal-title":"Nat. Commun."},{"key":"22557_CR32","doi-asserted-by":"publisher","first-page":"14607","DOI":"10.1073\/pnas.241517298","volume":"98","author":"B Bj\u00f6rkholm","year":"2001","unstructured":"Bj\u00f6rkholm, B. et al. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc. Natl Acad. Sci. USA 98, 14607\u201314612 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22557_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/AAC.45.3.727-733.2001","volume":"45","author":"G Wang","year":"2001","unstructured":"Wang, G., Wilson, T. J. M., Jiang, Q. & Taylor, D. E. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 45, 727\u2013733 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"22557_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/modpathol.3800098","volume":"17","author":"S J\u00fcttner","year":"2004","unstructured":"J\u00fcttner, S. et al. Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue. Mod. Pathol. 17, 684\u2013689 (2004).","journal-title":"Mod. Pathol."},{"key":"22557_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/cjp2.57","volume":"3","author":"E Demiray\u2010G\u00fcrb\u00fcz","year":"2016","unstructured":"Demiray\u2010G\u00fcrb\u00fcz, E. et al. Rapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH. J. Pathol. Clin. Res. 3, 29\u201337 (2016).","journal-title":"J. Pathol. Clin. Res."},{"key":"22557_CR36","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3748\/wjg.v23.i16.2854","volume":"23","author":"N Arslan","year":"2017","unstructured":"Arslan, N., Y\u0131lmaz, \u00d6. & Demiray-G\u00fcrb\u00fcz, E. Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection. World J. Gastroenterol. 23, 2854\u20132869 (2017).","journal-title":"World J. Gastroenterol."},{"key":"22557_CR37","first-page":"235","volume":"20","author":"V De Francesco","year":"2011","unstructured":"De Francesco, V. et al. Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study. J. Gastrointestin. Liver. Dis. 20, 235\u2013239 (2011).","journal-title":"J. Gastrointestin. Liver. Dis."},{"key":"22557_CR38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1099\/jmm.0.000163","volume":"64","author":"T Fasciana","year":"2015","unstructured":"Fasciana, T. et al. Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily. J. Med. Microbiol. 64, 1408\u20131414 (2015).","journal-title":"J. Med. Microbiol."},{"key":"22557_CR39","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/jac\/dkw054","volume":"71","author":"W Schr\u00f6der","year":"2016","unstructured":"Schr\u00f6der, W. et al. Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. J. Antimicrob. Chemother. 71, 1800\u20131806 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"22557_CR40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/1469-0691.12701","volume":"20","author":"N Almeida","year":"2014","unstructured":"Almeida, N. et al. Helicobacter pylori antimicrobial resistance rates in the central region of Portugal. Clin. Microbiol. Infect. 20, 1127\u20131133 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"22557_CR41","doi-asserted-by":"crossref","first-page":"e12640","DOI":"10.1111\/hel.12640","volume":"24","author":"A O\u2019Connor","year":"2019","unstructured":"O\u2019Connor, A., Liou, J.-M., Gisbert, J. P. & O\u2019Morain, C. Review: treatment of Helicobacter pylori infection 2019. Helicobacter 24, e12640 (2019).","journal-title":"Helicobacter"},{"key":"22557_CR42","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1128\/JCM.39.11.4142-4144.2001","volume":"39","author":"H R\u00fcssmann","year":"2001","unstructured":"R\u00fcssmann, H. et al. Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. J. Clin. Microbiol. 39, 4142\u20134144 (2001).","journal-title":"J. Clin. Microbiol."},{"key":"22557_CR43","first-page":"e000344","volume":"6","author":"AT Marques","year":"2020","unstructured":"Marques, A. T., V\u00edtor, J. M. B., Santos, A., Oleastro, M. & Vale, F. F. Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches. Microb. Genom. 6, e000344 (2020).","journal-title":"Microb. Genom."},{"key":"22557_CR44","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1128\/AAC.49.2.868-870.2005","volume":"49","author":"C Burucoa","year":"2005","unstructured":"Burucoa, C., Landron, C., Garnier, M. & Fauch\u00e8re, J.-L. T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 49, 868\u2013870 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"22557_CR45","doi-asserted-by":"publisher","first-page":"e12387","DOI":"10.1111\/hel.12387","volume":"22","author":"\u00c9 Kocsm\u00e1r","year":"2017","unstructured":"Kocsm\u00e1r, \u00c9. et al. Sensitivity of Helicobacter pylori detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory activity. Helicobacter 22, e12387 (2017).","journal-title":"Helicobacter"},{"key":"22557_CR46","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"Dixon, M. F. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20, 1161\u20131181 (1996).","journal-title":"Am. J. Surg. Pathol."},{"key":"22557_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1155\/2001\/367832","volume":"15","author":"M Stolte","year":"2001","unstructured":"Stolte, M. & Meining, A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can. J. Gastroenterol. 15, 591\u2013598 (2001).","journal-title":"Can. J. Gastroenterol."},{"key":"22557_CR48","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/apt.15273","volume":"49","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment. Aliment. Pharmacol. Ther. 49, 1385\u20131394 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"22557_CR49","doi-asserted-by":"crossref","first-page":"175628481987492","DOI":"10.1177\/1756284819874922","volume":"12","author":"L Yu","year":"2019","unstructured":"Yu, L. et al. Susceptibility-guided therapy for Helicobacter pylori infection treatment failures. Ther. Adv. Gastroenterol. 12, 1756284819874922 (2019).","journal-title":"Ther. Adv. Gastroenterol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22557-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:19:17Z","timestamp":1698884357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22557"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22557-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"2 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2255"}}